Skip to main content
Log in

Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases

Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Herbal remedies, supplements, and alternative therapeutic items are used by many patients with hypertension and cardiovascular diseases. Scientific knowledge about their efficacy and safety is lacking, and unfortunately, physicians are frequently not aware that patients are using these nontraditional forms of medical care. Patients may anticipate physicians’ disapproval of their use, or not realize that it is important for the physician to know what they are taking. Therefore, it is imperative that patients are asked nonjudgmental questions about current and past use of herbals and alternative therapies. Even when physicians are aware of such use, they feel poorly trained to identify the constituents and effects. Although many such therapies are innocuous, several herbal or alternative therapeutic items can significantly elevate blood pressure or cause interactions with cardiovascular drugs. Practitioners in cardiovascular medicine should be competent and know current scientific evidence for the benefits and adverse effects of herbal supplements and provide patients reasonable advice. In this brief article, we review the epidemiology of alternative therapy use, and select several important herbal or other supplements that patients with hypertension and cardiovascular diseases may be taking. We discuss the therapies considered biological in nature as opposed to mind-body interventions or manipulative body or energy therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Winslow LC, Kroll DJ: Herbs as medicines. Arch Intern Med 1998, 158:2192–2199. This review investigates pertinent definitions, the history of herbs in medicine, epidemiology and prevalence of herbal use, and relevant psychosocial issues.

    Article  PubMed  CAS  Google Scholar 

  2. Miller KL, Liebowitz RS, Newby LK: Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 2004, 147:401–411.

    Article  PubMed  Google Scholar 

  3. Rafferty AP, McGee HB, Miller CE, et al.: Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 2002, 92:1598–1600.

    PubMed  Google Scholar 

  4. CDC: Self-treatment with herbal and other plant-derived remedies—rural Mississippi, 1993. MMWR Morb Mortal Wkly Rep 1995, 44:204–207.

    Google Scholar 

  5. Harnack LJ, Rydell SA, Stang J: Prevalence of use of herbal products by adults in the Minneapolis/St. Paul, Minn, metropolitan area. Mayo Clin Proc 2001, 76:688–694.

    PubMed  CAS  Google Scholar 

  6. Final report of the White House Commission on Complementary and Alternative Medicine Policy. Available online at http://www.whccamp.hhs.gov/fr7.html Describes the economics, coverage, and reimbursement issues for herbal and complementary medicine.

  7. Eisenberg DM, Davis RB, Ettner SL, et al.: Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998, 280:1569–1575.

    Article  PubMed  CAS  Google Scholar 

  8. Cappuccio FP, Duneclift SM, Atkinson RW, et al.: Use of alternative medicines in a multi-ethnic population. Ethn Dis 2000, 11:11–18.

    Google Scholar 

  9. Mikhail N, Wali S, Ziment I: Use of alternative medicine among Hispanics. J Altern Complement Med 2004, 10:851–859.

    PubMed  Google Scholar 

  10. Eisenberg DM, Kessler RC, Van RompayMI, et al.: Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001, 135:344–351.

    PubMed  CAS  Google Scholar 

  11. Palinkas LA, Kabongo ML: San Diego Unified Practice Research in Family Medicine Network. The use of complementary and alternative medicine by primary care patients. A SURF*NET study. J Fam Pract 2000, 49:1121–1130.

    PubMed  CAS  Google Scholar 

  12. Fields LE, Burt VL, Cutler JA, et al.: The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004, 44:398–404.

    Article  PubMed  CAS  Google Scholar 

  13. Cohen MH: Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation. Dermatol Ther 2003, 16:777–784. Highlights legal rules governing CAM providers and practices. Additionally, significant developments, such as guidelines by the Federation of State Medical Boards to govern physician integration of CAM therapies, and recommendations for federal legislation and policy are presented.

    Article  Google Scholar 

  14. US Food and Drug Administration: Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Docket number: 1995N-0304. http://www.fda.gov/OHRMS/DOCKETS/98fr/ 1995n-0304-nfr0001.pdf. 2004.

  15. Banerjee SK, Maulik SK: Effect of garlic on cardiovascular disorders: a review. Nutr J 2002, 1:4.

    Article  PubMed  Google Scholar 

  16. Das I, Khan NS, Sooranna SR: Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin 1995, 13:257–263.

    PubMed  CAS  Google Scholar 

  17. Sharifi AM, Darabi R, Akbarloo N: Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat. J Ethnopharmacol 2003, 86:219–224.

    Article  PubMed  Google Scholar 

  18. Ackermann RT, Mulrow CD, Ramirez G, et al.: Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001, 161:813–824.

    Article  PubMed  CAS  Google Scholar 

  19. Silagy CA, Neil HA: A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994, 12:463–468.

    Article  PubMed  CAS  Google Scholar 

  20. Turner B, Molgaard C, Marckmann P: Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2004, 92:701–706.

    Article  PubMed  CAS  Google Scholar 

  21. Piscitelli SC, Burstein AH, Welden N, et al.: The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002, 35:234–238.

    Article  Google Scholar 

  22. Knuppel L, Linde K: Adverse effects of St. John’s Wort: a systematic review. J Clin Psychiatry 2004, 65:1470–1479.

    Article  PubMed  Google Scholar 

  23. Bilia AR, Gallori S, Vincieri FF: St. John’s Wort and depression: efficacy, safety and tolerability: an update. Life Sci 2002, 70:3077–3096.

    Article  PubMed  CAS  Google Scholar 

  24. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St. John’s Wort) in major depressive disorder: a randomized controlled trial. JAMA 2002, 287:1807–1814.

    Article  Google Scholar 

  25. Zullino D, Borgeat F: Hypertension induced by St. John’s Wort: a case report. Pharmacopsychiatry 2003, 36:32.

    Article  PubMed  CAS  Google Scholar 

  26. Patel S, Robinson R, Burk M: Hypertensive crisis associated with St. John’s Wort. Am J Med 2002, 112:507–508.

    Article  PubMed  Google Scholar 

  27. Markowitz JS, Donovan JL, DeVane CL, et al.: Effect of St John’s Wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003, 290:1500–1504. The ability of St. John’s Wort to alter the activity of the cytochrome P450 (CYP) enzymes after administrating for 14 days is assessed.

    Article  PubMed  CAS  Google Scholar 

  28. Mueller SC, Uehleke B, Woehling H, et al.: Effect of St John’s Wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 2004, 75:546–557.

    Article  PubMed  CAS  Google Scholar 

  29. Sugimoto K, Ohmori M, Tsuruoka S, et al.: Different effects of St John’s Wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001, 70:518–524.

    Article  PubMed  CAS  Google Scholar 

  30. Jiang X, Williams KM, Liauw WS, et al.: Effect of St John’s Wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004, 57:592–599.

    Article  PubMed  CAS  Google Scholar 

  31. Tannergren C, Engman H, Knutson L, et al.: St John’s Wort decreases the bioavailability of R-and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 2004, 75:298–309.

    Article  PubMed  CAS  Google Scholar 

  32. Mai I, Bauer S, Perloff ES, et al.: Hyperforin content determines the magnitude of the St John’s Wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004, 76:330–340.

    Article  PubMed  CAS  Google Scholar 

  33. Hebert MF, Park JM, Chen YL, et al.: Effects of St. John’s Wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004, 44:89–94.

    Article  PubMed  CAS  Google Scholar 

  34. Ruschitzka F, Meier PJ, Turina M, et al.: Acute heart transplant rejection due to St. John’s Wort. Lancet 2000, 355:548–549.

    Article  PubMed  CAS  Google Scholar 

  35. Ernst E: St John’s Wort supplements endanger the success of organ transplantation. Arch Surg 2002, 137:316–319.

    Article  PubMed  CAS  Google Scholar 

  36. Piscitelli SC, Burstein AH, Chaitt D, et al.: Indinavir concentrations and St. John’s Wort. Lancet 2000, 355:547–548.

    Article  PubMed  CAS  Google Scholar 

  37. de Maat MM, Hoetelmans RM, Math t RA, et al.: Drug interaction between St John’s Wort and nevirapine. AIDS 2001, 15:420–421.

    Article  PubMed  Google Scholar 

  38. Hall SD, Wang Z, Huang SM, et al.: The interaction between St John’s Wort and an oral contraceptive. Clin Pharmacol Ther 2003, 74:525–535.

    Article  PubMed  CAS  Google Scholar 

  39. Han KH, Choe SC, Kim HS, et al.: Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998, 26:199–209.

    Article  PubMed  CAS  Google Scholar 

  40. Caron MF, Hotsko AL, Robertson S, et al.: Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother 2002, 36:758–763.

    Article  PubMed  Google Scholar 

  41. Cicero AF, Derosa G, Brillante R, et al.: Effects of Siberian ginseng on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl 2004, 15:69–73.

    Article  Google Scholar 

  42. Achike FI, Kwan CY: Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 2003, 30:605–615.

    Article  PubMed  CAS  Google Scholar 

  43. Siegel RK: Ginseng abuse syndrome. Problems with the panacea. JAMA 1979, 241:1614–1615.

    Article  PubMed  CAS  Google Scholar 

  44. Yuan CS, Wei G, Dey L, et al.: American ginseng reduces warfarin’s effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004, 141:23–27.

    PubMed  CAS  Google Scholar 

  45. Walker BR, Edwards CR: Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 1994, 23:359–377.

    PubMed  CAS  Google Scholar 

  46. Quinkler M, Stewart PM: Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 2003, 88:2384–2392.

    Article  PubMed  CAS  Google Scholar 

  47. Russo S, Mastropasqua M, Mosetti MA, et al.: Low doses of liquorice can induce hypertension encephalopathy. Am J Nephrol 2000, 20:145–148.

    Article  PubMed  CAS  Google Scholar 

  48. Hasegawa J, Suyama Y, Kinugawa T, et al.: Echocardiographic findings of the heart resembling dilated cardiomyopathy during hypokalemic myopathy due to licorice-induced pseudoaldosteronism. Cardiovasc Drugs Ther 1998, 12:599–600.

    Article  PubMed  CAS  Google Scholar 

  49. Lin SH, Yang SS, Chau T, et al.: An unusual cause of hypokalemic paralysis: chronic licorice ingestion. Am J Med Sci 2003, 325:153–156.

    Article  PubMed  Google Scholar 

  50. Dellow EL, Unwin RJ, Honour JW: Pontefract cakes can be bad for you: Refractory hypertension and liquorice excess. Nephrol Dial Transplant 1999, 14:218–220.

    Article  PubMed  CAS  Google Scholar 

  51. Sigurjonsdottir HA, Manhem K, Axelson M, et al.: Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens 2003, 17:125–131.

    Article  PubMed  CAS  Google Scholar 

  52. Grossman E, Rosenthal T, Peleg E, et al.: Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol 1993, 22:22–26.

    Article  PubMed  CAS  Google Scholar 

  53. Goldberg MR, Hollister AS, Robertson D: Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans. Hypertension 1983, 5:772–778.

    PubMed  CAS  Google Scholar 

  54. Musso NR, Vergassola C, Pende A, et al.: Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens 1995, 8:565–557.

    Article  PubMed  CAS  Google Scholar 

  55. Ruck B, Shih RD, Marcus SM: Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med 1999, 17:317–318.

    Article  PubMed  CAS  Google Scholar 

  56. Onrot J, Goldberg MR, Biaggioni I, et al.: Oral yohimbine in human autonomic failure. Neurology 1987, 37:215–220.

    PubMed  CAS  Google Scholar 

  57. Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998, 159:433–436.

    Article  PubMed  CAS  Google Scholar 

  58. Kane GC, Lipsky JJ: Drug-grapefruit interactions. Mayo Clin Proceed 2000, 75:933–942. The medications involved in drug-grapefruit juice interactions are discussed, and the clinical implications of these interactions are addressed.

    Article  CAS  Google Scholar 

  59. Huang SM, Hall SD, Watkins P, et al.: Center for Drug Evaluation and Research and Office of Regulatory Affairs, Food and Drug Administration, Rockville, MD, USA. Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther 2004, 75:1–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vora, C.K., Mansoor, G.A. Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases. Current Science Inc 7, 275–280 (2005). https://doi.org/10.1007/s11906-005-0025-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-005-0025-0

Keywords

Navigation